Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics

Nephrology Dialysis Transplantation

Volumn 17, Issue 10, 2002, Pages 1758-1765

  Fleischmann, Erwin H ^a   Schlaich, Markus P ^a   Schmidt, Bernhard M W ^a   Oehmer, Sebastian ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Hypercholesterolaemia; L arginine; Nitric oxide; Renal haemodynamics

Indexed keywords

4 AMINOHIPPURIC ACID; ARGININE; CYCLIC GMP; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; INULIN CLEARANCE; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MALE; NATRIURESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOOTH MUSCLE RELAXATION; URINARY EXCRETION; VASCULAR SMOOTH MUSCLE;

EID: 0036799351     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.10.1758     Document Type: Article

References (20)

1. Casino PR, Kilcoyne CM, Quyyumi AA et al. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993; 88: 2541-2547
2. Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129-1135
3. Creager MA, Cooke JP, Mendelsohn ME et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-234
4. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991; 338: 1546-1550
5. John S, Schlaich MP, Langenfeld MRW et al. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation 1998; 98: 211-216
6. Na, and vasoactive hormones in healthy humans. Am J Physiol 1996; 39: F845-F851
7. Wolzt M, Schmetterer L, Ferber W et al. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Am J Physiol 1997; 272: F178-F182
8. Higashi Y, Oshima T, Ozono R et al. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension 1995; 25: 898-902
9. Mimran A, Ribstein J, du Cailar G. Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension 1995; 26: 937-941
10. Schmieder RE, Langenfeld MRW, Friedrich A et al. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996; 94: 1304-1309
11. Cole RB, Giangiacomo J, Ingelfinger JR, Robsa AU. Measurement of renal function without urine collection. A critical evaluation of the constant-infusion-technique for determination of inulin and para-aminohippurate clearance. N Engl J Med 1972; 287: 1109-1114
12. Mitchell JA, de Nucci G, Warner TD, Vane JR. Alkaline buffers release EDRF from bovine cultured endothelial cells. Br J Pharmacol 1991; 103: 1295-1302
13. Smith HW, Finkelstern N, Aliminosa L et al. The renal clearance of substituted hippuric acid derivates and other aromatic acids in dogs and man. J Clin Invest 1945; 24: 388-398
14. Schlaich MP, Jocobi J, Delles C et al. Is L-arginine an adequate tool to assess endothelial function of the human renal vasculature. Clin Sci 2000; 99: 293-302
15. Guigliano D, Marfella. R, Verrazzo G et al. L-arginine for testing endothelium dependent vascular function in health and disease. Am J Physiol 1997; 273: 606-612
16. Wennmalm A, Edlund A, Granstrom EF, Wiklund O. Acute supplementation with the nitric oxide precursor L-arginine does not improve cardiovascular performance in patients with hypercholesterolemia. Atherosclerosis 1995; 118: 223-231
17. Carroll JF, Mizelle HL, Cockrell K et al. Cholesterol feeding does not alter renal hemodynamic response to acetylcholine and angiotensin II in rabbits. Am J Physiol 1997; 272: R940-947
18. Cooke JP, Singer AH, Tsao P et al. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-1172
19. MacAllister J, Calver AL, Collier J et al. Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect. Clin Sci 1995; 89: 183-190
20. Sala C, Valentini P, Tortora G et al. Dissociation between plasma and urinary increments of cyclic GMP during saline infusion in essential hypertensive patients. J Hypertens 1998; 16: S144